115 related articles for article (PubMed ID: 29455030)
1. The clinical significance and biological function of tropomyosin 4 in colon cancer.
Yang R; Zheng G; Ren D; Chen C; Zeng C; Lu W; Li H
Biomed Pharmacother; 2018 May; 101():1-7. PubMed ID: 29455030
[TBL] [Abstract][Full Text] [Related]
2. The miR-133a, TPM4 and TAp63γ Role in Myocyte Differentiation Microfilament Remodelling and Colon Cancer Progression.
Caporali S; Calabrese C; Minieri M; Pieri M; Tarantino U; Marini M; D'Ottavio S; Angeletti S; Mauriello A; Cortese C; Bernardini S; Terrinoni A
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575979
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of clinical prognosis and molecular immune characterization of tropomyosin 4 in pancreatic cancer.
Zhou X; Zhu X; Yao J; Wang X; Wang N
Invest New Drugs; 2021 Dec; 39(6):1469-1483. PubMed ID: 33983530
[TBL] [Abstract][Full Text] [Related]
4. Loss of Tpm4.1 leads to disruption of cell-cell adhesions and invasive behavior in breast epithelial cells via increased Rac1 signaling.
Jeong S; Lim S; Schevzov G; Gunning PW; Helfman DM
Oncotarget; 2017 May; 8(20):33544-33559. PubMed ID: 28431393
[TBL] [Abstract][Full Text] [Related]
5. Integrated pan-cancer analysis and experimental verification of the roles of tropomyosin 4 in gastric cancer.
Guo Q; Zhao L; Yan N; Li Y; Guo C; Dang S; Shen X; Han J; Luo Y
Front Immunol; 2023; 14():1148056. PubMed ID: 36993958
[TBL] [Abstract][Full Text] [Related]
6. Cartilage oligomeric matrix protein is a prognostic factor and biomarker of colon cancer and promotes cell proliferation by activating the Akt pathway.
Liu TT; Liu XS; Zhang M; Liu XN; Zhu FX; Zhu FM; Ouyang SW; Li SB; Song CL; Sun HM; Lu S; Zhang Y; Lin J; Tang HM; Peng ZH
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1049-1063. PubMed ID: 29560517
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of eIF3e is correlated with colon tumor development and poor prognosis.
Li Z; Lin S; Jiang T; Wang J; Lu H; Tang H; Teng M; Fan J
Int J Clin Exp Pathol; 2014; 7(10):6462-74. PubMed ID: 25400724
[TBL] [Abstract][Full Text] [Related]
8. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
9. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
[TBL] [Abstract][Full Text] [Related]
10. Decreased MT1-MMP in gastric cancer suppressed cell migration and invasion via regulating MMPs and EMT.
Li W; Li S; Deng L; Yang S; Li M; Long S; Chen S; Lin F; Xiao L
Tumour Biol; 2015 Sep; 36(9):6883-9. PubMed ID: 25851348
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the predictive efficiency of S100P on adverse prognosis and the pathogenesis of S100P-mediated invasion and metastasis of colon adenocarcinoma.
Shen ZY; Fang Y; Zhen L; Zhu XJ; Chen H; Liu H; Jiang B; Li GX; Deng HJ
Cancer Genet; 2016 Apr; 209(4):143-53. PubMed ID: 26975699
[TBL] [Abstract][Full Text] [Related]
12. Nucleotide and protein sequences for dog masticatory tropomyosin identify a novel Tpm4 gene product.
Brundage EA; Biesiadecki BJ; Reiser PJ
J Muscle Res Cell Motil; 2015 Oct; 36(4-5):339-347. PubMed ID: 26400443
[TBL] [Abstract][Full Text] [Related]
13. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
14. SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
Cao LL; Pei XF; Qiao X; Yu J; Ye H; Xi CL; Wang PY; Gong ZL
Dig Dis Sci; 2018 Sep; 63(9):2309-2319. PubMed ID: 29855767
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA Fer-1-like protein 4 suppresses oncogenesis and exhibits prognostic value by associating with miR-106a-5p in colon cancer.
Yue B; Sun B; Liu C; Zhao S; Zhang D; Yu F; Yan D
Cancer Sci; 2015 Oct; 106(10):1323-32. PubMed ID: 26224446
[TBL] [Abstract][Full Text] [Related]
16. TPM4 promotes cell migration by modulating F-actin formation in lung cancer.
Zhao X; Jiang M; Wang Z
Onco Targets Ther; 2019; 12():4055-4063. PubMed ID: 31239699
[No Abstract] [Full Text] [Related]
17. ARMc8 indicates aggressive colon cancers and promotes invasiveness and migration of colon cancer cells.
Jiang G; Zhang Y; Zhang X; Fan C; Wang L; Xu H; Yu J; Wang E
Tumour Biol; 2015 Nov; 36(11):9005-13. PubMed ID: 26081621
[TBL] [Abstract][Full Text] [Related]
18. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte nuclear factor 4α suppresses the aggravation of colon carcinoma.
Yao HS; Wang J; Zhang XP; Wang LZ; Wang Y; Li XX; Jin KZ; Hu ZQ; Wang WJ
Mol Carcinog; 2016 May; 55(5):458-72. PubMed ID: 25808746
[TBL] [Abstract][Full Text] [Related]
20. Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack U; Walther W; Scudiero D; Selby M; Kobelt D; Lemm M; Fichtner I; Schlag PM; Shoemaker RH; Stein U
J Natl Cancer Inst; 2011 Jul; 103(13):1018-36. PubMed ID: 21685359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
